Pharmaceutical Business review

AmerisourceBergen to sell Canadian pharmaceutical distribution business

The estimated sale price is expected to be between $80m and $100m, of which approximately half will be financed by AmerisourceBergen.

ABCC represents approximately 2% of AmerisourceBergen’s total revenues.

AmerisourceBergen, however, will retain its Canadian specialty business.

The transaction, which is subject to customary closing conditions, is likely to close in the third quarter of fiscal 2013.

Exit mobile version